Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia

Resistance towards targeted cancer treatments caused by single nucleotide variations is a major issue in many malignancies. Currently, there are a number of available drugs for chronic myeloid leukaemia (CML), which are overcome by different sets of mutations.